Scorpius Holdings
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SCPX and buy or sell other stocks, ETFs, and their options commission-free!About SCPX
Scorpius Holdings, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness.
CEOJeff A. Wolf, MBA
CEOJeff A. Wolf, MBA
Employees84
Employees84
HeadquartersMorrisville, North Carolina
HeadquartersMorrisville, North Carolina
Founded2008
Founded2008
Employees84
Employees84
SCPX Key Statistics
Market cap2.16K
Market cap2.16K
Price-Earnings ratio-0.02
Price-Earnings ratio-0.02
Dividend yield—
Dividend yield—
Average volume13.08K
Average volume13.08K
High today$0.012
High today$0.012
Low today$0.012
Low today$0.012
Open price$0.012
Open price$0.012
Volume6.34K
Volume6.34K
52 Week high$146.00
52 Week high$146.00
52 Week low$0.012
52 Week low$0.012
Stock Snapshot
The current Scorpius Holdings(SCPX) stock price is $0.01, with a market capitalization of 2.16K. The stock trades at a price-to-earnings (P/E) ratio of -0.02.
During the trading session on 2026-03-15, Scorpius Holdings(SCPX) shares reached a daily high of $0.01 and a low of $0.01. At a current price of $0.01, the stock is 0.0% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 6.34K, compared to an average daily volume of 13.08K.
The stock's 52-week range extends from a low of $0.01 to a high of $146.00.
The stock's 52-week range extends from a low of $0.01 to a high of $146.00.
People also own
Based on the portfolios of people who own SCPX. This list is generated using Robinhood data, and it’s not a recommendation.